Close Menu

Columbia

A Columbia University team has retracted its integrative genomic analysis of Alzheimer's disease Nature paper due to research misconduct.

Mutations present in tissue from Barrett's esophagus may help predict progression to high-grade dysplasia or cancer.

Drug companies are rushing toward genomic databases to inform their searches for new drugs, Reuters reports.

Using chromosomal microarrays, a Columbia University Medical Center-led team identified large genomic imbalances in pediatric chronic kidney disease, linking them to other disorders.

With genotyping and retroelement insertion mapping, researchers identified a clonal form of leukemia that's transmitted horizontally between soft-shell clams.

Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.

Exome sequence data for nearly 9,300 individuals pointed to new and known risk genes for sporadic ALS, including genes contributing to innate immunity and autophagy.

The partners will build a new sequencing facility at Columbia to help uncover new drug targets for the drug-developer.

NEW YORK (GenomeWeb) – In Nature Genetics, an international team led by investigators at Columbia and Yale Universities unveiled previously unknown risk loci for IgA nephropathy, a kidney condi

NEW YORK (GenomeWeb) – The Regeneron Genetics Center, a wholly-owned subsidiary of Regeneron Pharmaceuticals, has partnered with Columbia University Medical Center, the Clinic for Special Children, and Baylor College of Medicine to study a variety of Mendelian diseases.

Pages

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

In Nature this week: epigenetic factors that prevent healthy aging and more.